A first-in-human clinical trial of optogenetic therapy in 10 patients with advanced retinitis pigmentosa found the treatment safe and linked it to improved light sensitivity and object-detection tasks, though functional gains remain modest.
Optogenetic Therapy Shows Promise for Restoring Vision in Retinitis Pigmentosa
A first-in-human clinical trial of optogenetic therapy in 10 patients with advanced retinitis pigmentosa found the treatment safe and linked it to improved light sensitivity and object-detection tasks, though functional gains remain modest.
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.
Same event, other desks
Story file →
en
Live-Service Gaming's Battle Royale for the Top Spot Leaves Little Room for Number Two
08.10 15:01
en
Live-Service Games Face Reckoning as Player Trust Erodes
08.10 15:02
en
Trump's 'Super Intelligence' Rebrand of AI Draws Scrutiny as Experts Question Terminology
08.10 17:00
de
«Fjord»: Sebastian Stan und Renate Reinsve in einem Drama über eine rumänische Familie in Norwegen
08.10 17:00